News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Foresite Capital Management IV, LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/11/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/12/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/10/2023 |
4
| Foresite Capital Management IV, LLC (10% Owner) has filed a Form 4 on Kinnate Biopharma Inc.|
Txns:
| Bought 1,550,956 shares
@ $2.8, valued at
$4.3M
Bought 229,044 shares
@ $2.8, valued at
$641.3k
|
|
| 02/22/2023 |
4
| Foresite Capital Management IV, LLC (10% Owner) has filed a Form 4 on Kinnate Biopharma Inc.|
Txns:
| Acquired 1,100,000 shares
@ $0 |
|
| 02/13/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/12/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/13/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/11/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/12/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/03/2021 |
4
| Foresite Capital Management III, LLC (10% Owner) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Disposed of 1,954,904 shares
@ $0
Acquired 8,276 shares
@ $0 |
|
| 08/13/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/14/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/16/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/10/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/09/2020 |
4
| Foresite Capital Management IV, LLC (10% Owner) has filed a Form 4 on Kinnate Biopharma Inc.|
Txns:
| Converted 9,171,643 shares
@ $0
Converted 500,001 shares
@ $0
Converted 166,667 shares
@ $0
Converted 6,347,893 preferred shares
@ $0
Converted 298,465 preferred shares
@ $0
Converted 99,488 preferred shares
@ $0
Converted 2,666,002 preferred shares
@ $0
Converted 55,922 preferred shares
@ $0
Converted 18,641 preferred shares
@ $0
Converted 157,222 preferred shares
@ $0
Converted 145,128 preferred shares
@ $0 |
|
| 12/04/2020 |
4
| Foresite Capital Management IV, LLC (10% Owner) has filed a Form 4 on Kinnate Biopharma Inc.|
Txns:
| Granted 500,000 shares
@ $20, valued at
$10M
Granted 375,000 shares
@ $20, valued at
$7.5M
Granted 125,000 shares
@ $20, valued at
$2.5M
|
|
| 12/03/2020 |
3
| Foresite Capital Management IV, LLC (10% Owner) has filed a Form 3 on Kinnate Biopharma Inc. |
| 11/13/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/13/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/28/2020 |
13F-HR/A
| Form 13F-HR/A - Quarterly report filed by institutional managers, Holdings: [Amend] |
| 05/14/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 03/02/2020 |
4
| Foresite Capital Management II, LLC (10% Owner) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Sold 302,776 shares
@ $17.07, valued at
$5.2M
Sold 425,457 shares
@ $17.07, valued at
$7.3M
Sold 271,767 shares
@ $17.07, valued at
$4.6M
|
|
| 12/23/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/05/2019 |
4
| Foresite Capital Management IV, LLC (10% Owner) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Exercised (in-or-at-the-money) 44 options to buy
@ $30, valued at
$1.3k
Exercised (in-or-at-the-money) 266 options to buy
@ $30, valued at
$8k
|
|
| 11/18/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/13/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/05/2019 |
3/A
| Form 3/A - Initial statement of beneficial ownership of securities: [Amend] |
| 09/11/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/06/2019 |
4
| Foresite Capital Management II, LLC (10% Owner) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Bought 9,300 shares
@ $18.48, valued at
$171.9k
Bought 90,900 shares
@ $18.48, valued at
$1.7M
Bought 15,700 shares
@ $18.42, valued at
$289.2k
|
|
| 09/04/2019 |
4
| Foresite Capital Management II, LLC (10% Owner) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Bought 25,000 shares
@ $21.36, valued at
$534k
Bought 34,900 shares
@ $20.54, valued at
$716.8k
Bought 15,100 shares
@ $21.45, valued at
$323.9k
|
|
| 08/23/2019 |
4
| Foresite Capital Management II, LLC (10% Owner) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Bought 1,153 shares
@ $23.25, valued at
$26.8k
Bought 6,700 shares
@ $23.68, valued at
$158.7k
Bought 38,300 shares
@ $23.42, valued at
$897k
|
|
| 08/20/2019 |
4
| Foresite Capital Management II, LLC (10% Owner) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Bought 100,000 shares
@ $24.23, valued at
$2.4M
Bought 3,847 shares
@ $23.34, valued at
$89.8k
Bought 50,000 shares
@ $23.21, valued at
$1.2M
|
|
|
|
|